Total Payments
$40,649
2024 Payments
$8,989
Companies
27
Transactions
219
Medicare Patients
1,187
Medicare Billing
$121,648
Payment Breakdown by Category
Other$32,000 (78.7%)
Food & Beverage$7,356 (18.1%)
Travel$1,294 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,000 | 12 | 78.7% |
| Food and Beverage | $7,356 | 197 | 18.1% |
| Travel and Lodging | $1,294 | 10 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $29,945 | 99 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $7,479 | 16 | $0 (2021) |
| Gilead Sciences, Inc. | $877.72 | 32 | $0 (2024) |
| Boston Scientific Corporation | $401.48 | 11 | $0 (2024) |
| Daiichi Sankyo Inc. | $306.95 | 10 | $0 (2023) |
| Madrigal Pharmaceuticals | $247.38 | 5 | $0 (2024) |
| Covidien LP | $204.32 | 2 | $0 (2019) |
| Janssen Biotech, Inc. | $202.52 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $150.76 | 6 | $0 (2024) |
| Shire North American Group Inc | $125.72 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,989 | 52 | ABBVIE INC. ($7,893) |
| 2023 | $8,723 | 38 | ABBVIE INC. ($8,102) |
| 2022 | $13,309 | 52 | ABBVIE INC. ($12,991) |
| 2021 | $821.39 | 23 | AbbVie Inc. ($651.94) |
| 2020 | $215.19 | 5 | AbbVie Inc. ($152.11) |
| 2019 | $572.25 | 17 | Boston Scientific Corporation ($268.17) |
| 2018 | $200.54 | 10 | AbbVie, Inc. ($85.14) |
| 2017 | $7,819 | 22 | Merck Sharp & Dohme Corporation ($7,354) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: GALLSTONES | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.95 | General |
| 11/21/2024 | Micro-tech Endoscopy USA, Inc. | eyeMAX (Device) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: GI Endoscopy | ||||||
| 11/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $84.34 | General |
| Category: VIROLOGY | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $148.75 | General |
| 11/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: LIVER DISEASE | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.90 | General |
| 10/27/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $141.90 | General |
| Category: LIVER DISEASE | ||||||
| 10/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $99.79 | General |
| Category: VIROLOGY | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.37 | General |
| 10/22/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: GI COLON PREP | ||||||
| 10/18/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: VIROLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Travel and Lodging | In-kind items and services | $95.16 | General |
| Category: VIROLOGY | ||||||
| 10/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: LIVER DISEASE | ||||||
| 10/11/2024 | ABBVIE INC. | MAVYRET (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: VIROLOGY | ||||||
| 10/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.30 | General |
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: LIVER DISEASE | ||||||
| 09/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $124.39 | General |
| Category: VIROLOGY | ||||||
| 09/09/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.16 | General |
| 08/23/2024 | FUJIFILM Healthcare Americas Corporation | FUJIFILM (Device) | Food and Beverage | In-kind items and services | $100.81 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 252 | 306 | $75,575 | $25,395 |
| 2022 | 5 | 250 | 296 | $66,285 | $23,117 |
| 2021 | 9 | 395 | 466 | $125,530 | $44,193 |
| 2020 | 9 | 290 | 335 | $85,490 | $28,943 |
Total Patients
1,187
Total Services
1,403
Medicare Billing
$121,648
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 67 | $21,440 | $7,834 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 66 | $11,220 | $4,696 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 61 | 78 | $12,090 | $4,238 | 35.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 11 | 11 | $6,710 | $2,256 | 33.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $4,950 | $1,686 | 34.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 24 | 24 | $4,800 | $1,568 | 32.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,510 | $1,099 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 17 | $3,655 | $1,090 | 29.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $7,200 | $927.10 | 12.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 59 | 63 | $20,160 | $7,572 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 69 | 87 | $13,545 | $5,104 | 37.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 58 | $9,860 | $3,718 | 37.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 35 | 35 | $7,000 | $2,500 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 24 | $5,160 | $1,673 | 32.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $6,240 | $1,444 | 23.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $4,320 | $1,108 | 25.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 65 | 67 | $21,440 | $8,638 | 40.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 62 | 92 | $14,700 | $5,543 | 37.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 52 | 52 | $10,400 | $4,126 | 39.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 58 | $9,860 | $3,920 | 39.8% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 21 | 21 | $9,765 | $3,599 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 47 | $10,190 | $3,598 | 35.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 25 | 25 | $12,510 | $3,405 | 27.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $9,045 | $3,024 | 33.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 24 | $7,330 | $2,811 | 38.4% |
About Dr. Madhavi Reddy, M.D
Dr. Madhavi Reddy, M.D is a Specialist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467565499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Madhavi Reddy, M.D has received a total of $40,649 in payments from pharmaceutical and medical device companies, with $8,989 received in 2024. These payments were reported across 219 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,000).
As a Medicare-enrolled provider, Reddy has provided services to 1,187 Medicare beneficiaries, totaling 1,403 services with total Medicare billing of $121,648. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Brooklyn, NY
- Active Since 08/16/2006
- Last Updated 10/29/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467565499
Products in Payments
- MAVYRET (Drug) $26,670
- ZEPATIER (Drug) $7,412
- SKYRIZI (Biological) $2,455
- INJECTAFER (Drug) $306.95
- RINVOQ (Biological) $268.01
- HUMIRA (Biological) $265.09
- RESMETIROM (Drug) $247.38
- GENERAL THERAPIES (Device) $231.19
- Small Bowel (Device) $180.91
- GATTEX (Drug) $164.44
- STELARA (Biological) $141.86
- ZEPOSIA (Drug) $114.84
- FUJIFILM (Device) $100.81
- LINZESS (Drug) $98.70
- ENTYVIO (Biological) $94.03
- BREATHTEK (Device) $88.18
- Mavyret (Drug) $82.20
- DIFICID (Drug) $66.84
- REMICADE (Biological) $60.66
- ZENPEP (Drug) $47.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Brooklyn
Idan Sharon, M.d, M.D
Specialist — Payments: $2.3M
Specialist $2.3M
Dr. Sean Studer, M.d, M.D
Specialist — Payments: $411,591
Specialist $411,591
Dr. Michael Lewis, M.d, M.D
Specialist — Payments: $68,268
Specialist $68,268
Dr. Marc Avram, Md, MD
Specialist — Payments: $48,018
Specialist $48,018
Michael Amoashiy, Md, MD
Specialist — Payments: $41,408
Specialist $41,408
Mr. Benjamin Wu
Specialist — Payments: $23,392
Specialist $23,392